Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 464

1.

Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.

Kim JE, Ki MH, Yoon IS, Cho HJ, Kim RS, Tae Kim G, Kim DD.

Clin Ther. 2014 Feb 1;36(2):273-9. doi: 10.1016/j.clinthera.2014.01.004.

PMID:
24529292
2.

Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers.

Iqbal M, Khuroo A, Batolar LS, Tandon M, Monif T, Sharma PL.

Clin Ther. 2010 Mar;32(3):588-96. doi: 10.1016/j.clinthera.2010.03.004.

PMID:
20399995
3.

Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.

Spínola AC, Almeida S, Filipe A, Neves R, Trabelsi F, Farré A.

Clin Ther. 2009 Sep;31(9):1992-2001. doi: 10.1016/j.clinthera.2009.09.002.

PMID:
19843489
4.

Pharmacokinetic comparison of 2 fixed-dose combination tablets of amlodipine and valsartan in healthy male Korean volunteers: a randomized, open-label, 2-period, single-dose, crossover study.

Kim Y, Son M, Lee D, Roh H, Son H, Chae D, Bahng MY, Park K.

Clin Ther. 2013 Jul;35(7):934-40. doi: 10.1016/j.clinthera.2013.05.021.

5.
6.
7.

Single-dose, randomized crossover comparisons of different-strength imatinib mesylate formulations in healthy Korean male subjects.

Kim KA, Park SJ, Kim C, Park JY.

Clin Ther. 2013 Oct;35(10):1595-602. doi: 10.1016/j.clinthera.2013.08.008. Epub 2013 Sep 21.

PMID:
24060561
9.

Pharmacokinetic comparison of sustained- and immediate-release oral formulations of cilostazol in healthy Korean subjects: a randomized, open-label, 3-part, sequential, 2-period, crossover, single-dose, food-effect, and multiple-dose study.

Lee D, Lim LA, Jang SB, Lee YJ, Chung JY, Choi JR, Kim K, Park JW, Yoon H, Lee J, Park MS, Park K.

Clin Ther. 2011 Dec;33(12):2038-53. doi: 10.1016/j.clinthera.2011.10.024. Epub 2011 Nov 29.

PMID:
22129569
10.
11.

Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: a randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers.

Parrillo-Campiglia S, Ercoli MC, Umpierrez O, Rodríguez P, Márquez S, Guarneri C, Estevez-Parrillo FT, Laurenz M, Estevez-Carrizo FE.

Clin Ther. 2009 Oct;31(10):2224-32. doi: 10.1016/j.clinthera.2009.10.009.

PMID:
19922893
12.
14.
15.

Comparative pharmacokinetic evaluation of two formulations of bicalutamide 50-mg tablets: an open-label, randomized-sequence, single-dose, two-period crossover study in healthy Korean male volunteers.

Lee S, Chung YJ, Kim BH, Shim JH, Yoon SH, Shin SG, Jang IJ, Yu KS.

Clin Ther. 2009 Dec;31(12):3000-8. doi: 10.1016/j.clinthera.2009.12.004.

PMID:
20110037
16.

Comparative fasting bioavailability of 2 bepotastine formulations in healthy male Chinese volunteers: an open-label, randomized, single-dose, 2-way crossover study.

Shentu J, Zhou H, Hu X, Wu G, Wu L, Zhu M, Zhai Y, Zheng Y, Liu J.

Clin Ther. 2014 Apr 1;36(4):579-85. doi: 10.1016/j.clinthera.2014.02.020. Epub 2014 Mar 18.

PMID:
24656153
17.

Pharmacokinetics and bioavailability comparison of generic and branded citalopram 20 mg tablets: an open-label, randomized-sequence, two-period crossover study in healthy Chinese CYP2C19 extensive metabolizers.

Jiang T, Rong Z, Xu Y, Chen B, Xie Y, Chen C, Lu Y, Shen Y, Li H, Sun J, Chen H.

Clin Drug Investig. 2013 Jan;33(1):1-9. doi: 10.1007/s40261-012-0010-8.

PMID:
23179471
18.
19.

Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.

Palma-Aguirre JA, Villalpando-Hernández J, Novoa-Heckel G, Oliva I, Cariño L, López-Bojórquez E, Burke-Fraga V, Namur S, González-de la Parra M.

Clin Ther. 2009 Feb;31(2):399-410. doi: 10.1016/j.clinthera.2009.02.002.

PMID:
19302912
20.

Single-dose pharmacokinetic properties, bioavailability, and tolerability of two lamivudine 100-mg tablet formulations: a randomized crossover study in healthy Chinese male subjects.

Li X, Liu B, Sun Y, Chen H, Chen H, Zhang H, Zhang Q, Ding Y.

Clin Ther. 2013 Oct;35(10):1546-56. doi: 10.1016/j.clinthera.2013.07.431. Epub 2013 Sep 5.

PMID:
24011635
Items per page

Supplemental Content

Write to the Help Desk